Intranasal Inoculation of White-Tailed Deer (Odocoileus virginianus) with Lyophilized Chronic Wasting Disease Prion Particulate Complexed to Montmorillonite Clay

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Nichols, Tracy A ^a   Spraker, Terry R ^b   Rigg, Tara D ^a   Meyerett Reid, Crystal ^b   Hoover, Clare ^b   Michel, Brady ^b   Bian, Jifeng ^b   Hoover, Edward ^b   Gidlewski, Thomas ^a   Balachandran, Aru ^c   O'Rourke, Katherine ^d,e   Telling, Glenn C ^b   Bowen, Richard ^b   Zabel, Mark D ^b   VerCauteren, Kurt C ^a  

^a NATIONAL WILDLIFE RESEARCH CENTER   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c CANADIAN FOOD INSPECTION AGENCY   (Canada)

^d AGRICULTURAL RESEARCH SERVICE   (United States)

^e WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ANIMAL HUSBANDRY; ARTICLE; CHRONIC WASTING DISEASE; CLAY; CODON; CONTROLLED STUDY; DISEASE TRANSMISSION; DUST; FORAGING; GASTROINTESTINAL INFECTION; GENOTYPE; HOMOZYGOSITY; IMMUNOHISTOCHEMISTRY; INOCULATION; MONTMORILLONITE CLAY; NATURAL HOST; NONHUMAN; POPULATION EXPOSURE; PRION DISEASE; WESTERN BLOTTING; WHITE TAILED DEER;

ADMINISTRATION, INTRANASAL; ALUMINUM SILICATES; ANIMALS; ANIMALS, WILD; BENTONITE; DEER; FEMALE; FREEZE DRYING; GENOTYPE; IMMUNOHISTOCHEMISTRY; LYMPHOID TISSUE; MALE; PRIONS; TIME FACTORS; WASTING DISEASE, CHRONIC;

EID: 84877324595     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062455     Document Type: Article

References (67)

1. Saunders SE, Bartelt-Hunt SL, Bartz JC, (2012) Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 18: 369-376.
2. Prusiner SB, (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
3. Miller MW, Williams ES, (2003) Prion disease: horizontal prion transmission in mule deer. Nature 425: 35-36.
4. Miller MW, Williams ES, Hobbs NT, Wolfe LL, (2004) Environmental sources of prion transmission in mule deer. Emerg Infect Dis 10: 1003-1006.
5. Haley NJ, Seelig DM, Zabel MD, Telling GC, Hoover EA, (2009) Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay. PLoS One 4: e4848.
6. Pulford B, Spraker TR, Wyckoff AC, Meyerett C, Bender H, et al. (2012) Detection of PrPCWD in feces from naturally exposed Rocky Mountain elk (Cervus elaphus nelsoni) using protein misfolding cyclic amplification. J Wildl Dis 48: 425-434.
7. Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, et al. (2006) Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314: 133-136.
8. Karberg NJ, Lilleskov EA, (2009) White-tailed deer (Odocoileus virginianus) fecal pellet decomposition is accelerated by the invasive earthworm Lumbricus terrestris. Biological Invasions 11: 761-767.
9. Johnson CJ, Phillips KE, Schramm PT, McKenzie D, Aiken JM, et al. (2006) Prions adhere to soil minerals and remain infectious. PLoS Pathog 2: e32.
10. Wiggins RC, (2009) Prion stability and infectivity in the environment. Neurochem Res 34: 158-168.
11. Rigou P, Rezaei H, Grosclaude J, Staunton S, Quiquampoix H, (2006) Fate of prions in soil: adsorption and extraction by electroelution of recombinant ovine prion protein from montmorillonite and natural soils. Environ Sci Technol 40: 1497-1503.
12. Saunders SE, Yuan Q, Bartz JC, Bartelt-Hunt S, (2011) Effects of solution chemistry and aging time on prion protein adsorption and replication of soil-bound prions. PLoS One 6: e18752.
13. Arthur WJ III, Allderdge AW, (1979) Soil Ingestion by Mule Deer in Northcentral Colorado. Journal of Range Management 32: 67-71.
14. Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O'Rourke KI, et al. (1999) Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 80 (Pt 10) (): 2757-2764.
15. Fox KA, Jewell JE, Williams ES, Miller MW, (2006) Patterns of PrPCWD accumulation during the course of chronic wasting disease infection in orally inoculated mule deer (Odocoileus hemionus). J Gen Virol 87: 3451-3461.
16. Johnson CJ, Pedersen JA, Chappell RJ, McKenzie D, Aiken JM, (2007) Oral transmissibility of prion disease is enhanced by binding to soil particles. PLoS Pathog 3: e93.
17. Hewitt D, G., editor (2011) Biology and Mangament of White-tailed Deer. Boca Raton, FL: CRC Press. 674 p.
18. Tweill DEaT, JW, editor (2002) North American Elk Ecology and Management. Washington: Smithsonian Institution Press. 962 p.
19. Bessen RA, Martinka S, Kelly J, Gonzalez D, (2009) Role of the lymphoreticular system in prion neuroinvasion from the oral and nasal mucosa. J Virol 83: 6435-6445.
20. Sbriccoli M, Cardone F, Valanzano A, Lu M, Graziano S, et al. (2009) Neuroinvasion of the 263K scrapie strain after intranasal administration occurs through olfactory-unrelated pathways. Acta Neuropathol 117: 175-184.
21. Kincaid AE, Bartz JC, (2007) The nasal cavity is a route for prion infection in hamsters. J Virol 81: 4482-4491.
22. Denkers ND, Hayes-Klug J, Anderson KR, Seelig DM, Haley NJ, et al. (2013) Aerosol transmission of chronic wasting disease in white-tailed deer. J Virol 87: 1890-1892.
23. Nichols TA, Pulford B, Wyckoff AC, Meyerett C, Michel B, et al. (2009) Detection of protease-resistant cervid prion protein in water from a CWD-endemic area. Prion 3: 171-183.
24. Gee GW, Bauder J.W. (1986) Particle size analysis. In: Klute A, editor. Methods of Soil Analaysis, Part 1. Second ed. pp. 399-404.
25. Bian J, Napier D, Khaychuck V, Angers R, Graham C, et al. (2010) Cell-based quantification of chronic wasting disease prions. J Virol 84: 8322-8326.
26. Michel B, Meyerett-Reid C, Johnson T, Ferguson A, Wyckoff C, et al. (2012) Incunabular immunological events in prion trafficking. Sci Rep 2: 440.
27. Spraker TR, O'Rourke KI, Balachandran A, Zink RR, Cummings BA, et al. (2002) Validation of monoclonal antibody F99/97.6.1 for immunohistochemical staining of brain and tonsil in mule deer (Odocoileus hemionus) with chronic wasting disease. J Vet Diagn Invest 14: 3-7.
28. Mathiason CK, Hays SA, Powers J, Hayes-Klug J, Langenberg J, et al. (2009) Infectious prions in pre-clinical deer and transmission of chronic wasting disease solely by environmental exposure. PLoS One 4: e5916.
29. Strotmann J, (2001) Targeting of olfactory neurons. Cell Mol Life Sci 58: 531-537.
30. Le Pichon CE, Firestein S, (2008) Expression and localization of the prion protein PrP(C) in the olfactory system of the mouse. J Comp Neurol 508: 487-499.
31. Flexner S, Clark PF, (1912) A note on the mode of infection in epidemic poliomyelitis. Proc Soc Expl Biol Med 10: 1-2.
32. Esiri MM, Tomlinson AH, (1984) Herpes simplex encephalitis. Immunohistological demonstration of spread of virus via olfactory and trigeminal pathways after infection of facial skin in mice. J Neurol Sci 64: 213-217.
33. Lafay F, Coulon P, Astic L, Saucier D, Riche D, et al. (1991) Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183: 320-330.
34. Larsson P, Tjalve H, (2000) Intranasal instillation of aflatoxin B(1) in rats: bioactivation in the nasal mucosa and neuronal transport to the olfactory bulb. Toxicol Sci 55: 383-391.
35. Bessen RA, Shearin H, Martinka S, Boharski R, Lowe D, et al. (2010) Prion shedding from olfactory neurons into nasal secretions. PLoS Pathog 6: e1000837.
36. Klaassen CD, editor(2001) Casarett and Doull's Toxicology. The Basic Science of Poisons. Sixth ed. New York: McGraw-Hill. 1236 p.
37. Feng SS, Mei L, Anitha P, Gan CW, Zhou W, (2009) Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 30: 3297-3306.
38. Kawase M, Hayashi Y, Kinoshita F, Yamato E, Miyazaki J, et al. (2004) Protective effect of montmorillonite on plasmid DNA in oral gene delivery into small intestine. Biol Pharm Bull 27: 2049-2051.
39. Dong Y, Feng SS, (2005) Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 26: 6068-6076.
40. Jani PU, McCarthy DE, Florence AT, (1992) Nanosphere and microsphere uptake via Peyer's patches: observation of the rate of uptake in the rat after a single oral dose. International Journal of Pharmaceutics pp. 239-246.
41. Rajapaksa TE, Stover-Hamer M, Fernandez X, Eckelhoefer HA, Lo DD, (2010) Claudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery. J Control Release 142: 196-205.
42. Upham JW, (2003) The role of dendritic cells in immune regulation and allergic airway inflammation. Respirology 8: 140-148.
43. Huang FP, Farquhar CF, Mabbott NA, Bruce ME, MacPherson GG, (2002) Migrating intestinal dendritic cells transport PrP(Sc) from the gut. J Gen Virol 83: 267-271.
44. Sansonetti PJ, Phalipon A, (1999) M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. Semin Immunol 11: 193-203.
45. Annacker O, Coombes JL, Malmstrom V, Uhlig HH, Bourne T, et al. (2005) Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J Exp Med 202: 1051-1061.
46. Jepson MA, Clark MA, Foster N, Mason CM, Bennett MK, et al. (1996) Targeting to intestinal M cells. J Anat 189 (Pt 3) (): 507-516.
47. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, et al. (2001) Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol 2: 361-367.
48. Xia W, Pinto CE, Kradin RL, (1995) The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen. J Exp Med 181: 1275-1283.
49. Huang FP, MacPherson GG, (2004) Dendritic cells and oral transmission of prion diseases. Adv Drug Deliv Rev 56: 901-913.
50. Donaldson DS, Kobayashi A, Ohno H, Yagita H, Williams IR, et al. (2012) M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol 5: 216-225.
51. Mabbott NA, (2012) Prion pathogenesis and secondary lymphoid organs (SLO): Tracking the SLO spread of prions to the brain. Prion 6: 322-333.
52. Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, et al. (2001) Transepithelial prion transport by M cells. Nat Med 7: 976-977.
53. Holt PG, Stumbles PA, (2000) Regulation of immunologic homeostasis in peripheral tissues by dendritic cells: the respiratory tract as a paradigm. J Allergy Clin Immunol 105: 421-429.
54. Hartmann E, Graefe H, Hopert A, Pries R, Rothenfusser S, et al. (2006) Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol 13: 1278-1286.
55. KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, et al. (2006) An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 118: 1117-1125.
56. McWilliam AS, Nelson DJ, Holt PG, (1995) The biology of airway dendritic cells. Immunol Cell Biol 73: 405-413.
57. Holt PG, Schon-Hegrad MA, Phillips MJ, McMenamin PG, (1989) Ia-positive dendritic cells form a tightly meshed network within the human airway epithelium. Clin Exp Allergy 19: 597-601.
58. Takano K, Kojima T, Go M, Murata M, Ichimiya S, et al. (2005) HLA-DR- and CD11c-positive dendritic cells penetrate beyond well-developed epithelial tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem 53: 611-619.
59. Kincaid AE, Hudson KF, Richey MW, Bartz JC, (2012) Rapid Transepithelial Transport of Prions Following Inhalation. J Virol 86: 12741-12740.
60. Yeo NK, Hwang YJ, Kim ST, Kwon HJ, Jang YJ, (2010) Asian sand dust enhances rhinovirus-induced cytokine secretion and viral replication in human nasal epithelial cells. Inhal Toxicol 22: 1038-1045.
61. Nelson HS, (2007) Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 119: 872-880.
62. KleinJan A, (2011) The crucial role of dendritic cells in rhinitis. Curr Opin Allergy Clin Immunol 11: 12-17.
63. Keeler AP, Bernarsky NL, Huffman JE, Roscoe DE, (2011) A survey of the prion protein gene heterogeneity in New Jersey white-tailed deer (Odocoileus virginianus). Jounral of the Pennsylvania Acadamy of Science 85: 183-187.
64. Kelly AC, Mateus-Pinilla NE, Diffendorfer J, Jewell E, Ruiz MO, et al. (2008) Prion sequence polymorphisms and chronic wasting disease resistance in Illinois white-tailed deer (Odocoileus virginianus). Prion 2: 28-36.
65. Robinson SJ, Samuel MD, Johnson CJ, Adams M, McKenzie DI, (2012) Emerging prion disease drives host selection in a wildlife population. Ecol Appl 22: 1050-1059.
66. Sigurdson CJ, Barillas-Mury C, Miller MW, Oesch B, van Keulen LJ, et al. (2002) PrP(CWD) lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J Gen Virol 83: 2617-2628.
67. Miller MW, Wolfe LL, Sirochman TM, Sirochman MA, Jewell JE, et al. (2012) Survival patterns in white-tailed and mule deer after oral inoculation with a standardized, conspecific prion dose. J Wildl Dis 48: 526-529.